DexCom Inc (DXCM)
$69.41+1.11%
Spriggl Score: Strong— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Top glucose monitor franchise with new clinical proof for the Type 2 market; premium price remains the caution.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About DexCom Inc
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Da…
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- $28.0B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across DexCom Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free